cro.directory
← Compare landing

Accelera Srl vs Oncodesign Services

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/accelera/oncodesign-services

CategoryAccelera SrlOncodesign Services
Listed sitecrocro
SummaryEurope-based preclinical CRO specializing in GLP-compliant toxicology, safety assessment, and efficacy testing for small molecules and biologics, with AAALAC accreditation and integrated translational research capabilities.Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.
Services
  • GLP Toxicology
  • DART (Reproductive & Developmental Toxicology)
  • Safety Pharmacology
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Translational Research
  • Regulatory Affairs
  • Discovery Research
  • Target Identification & Validation
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Specialized & Large-Animal Models
  • Bioanalysis
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Clinical Imaging Core Lab
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • Virology Services
  • GLP Toxicology
  • Safety Pharmacology
  • Translational Research
  • Preclinical In Vitro Studies
  • Regulatory Affairs
  • LC-MS Bioanalysis (Small Molecule)
  • High-Throughput Screening
  • Genetic Toxicology
  • Computational & In-Silico Drug Discovery
  • Carcinogenicity Studies
  • DART (Reproductive & Developmental Toxicology)
  • Flow Cytometry Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Ligand-Binding Bioanalysis (Large Molecule)
Modalities
  • Small Molecule
  • Biologics (Other)
  • Small Molecule
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
Indications
  • Oncology
  • Oncology
  • Immunology
  • Infectious Disease
  • Dermatology
  • Gastroenterology
  • Nephrology
  • Metabolic
  • Rare Disease
  • Respiratory
Locations
  • Headquarters, Milan, Italy
  • Headquarters, Dijon, Bourgogne-Franche-Comté, France
  • Headquarters
Certifications
  • AAALAC · Identifier: AAALAC accreditation
  • GLP · Identifier: GLP compliance
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.